|
|
Article: US pharma major Bristol-Myers Squibb is acquiring New Jersey biotech firm Medarex for around $2.4bn.(Companies, technology & environment)
- Article from:
- Chemistry and Industry
- Article date:
- August 10, 2009
- Author:
CopyrightCOPYRIGHT 2009 Society of Chemical Industry. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
US pharma major Bristol-Myers Squibb is acquiring New Jersey biotech firm Medarex for around $2.4bn. Bristol-Myers already owned a 2% share of the company as a result of a joint programme begun in 2005 to develop a treatment for melanoma. Medarex has developed transgenic mice with ...
Related newspaper, magazine, and journal articles:
|
|
Article: Patent No. 7,615,556 Issued on Nov. 10, Assigned to ...
US Fed News Service, Including US State News;
November 11, 2009 ;
422 words
... ... derivative. The inventors were issued U.S. Patent No. 7,615,556 on Nov. 10. The patent has been assigned to Bristol-Myers Squibb Co., Princeton. According to the abstract released by the U.S. Patent & Trademark Office: "The present application ...
|
|